Metabolic effects of high-dose glucocorticoid following out-of-hospital cardiac arrest

被引:0
作者
Beske, Rasmus Paulin [1 ,2 ]
Obling, Laust Emil Roelsgaard [1 ]
Meyer, Martin Abild Stengaard [1 ]
Moller, Jacob Eifer [1 ,3 ]
Kjaergaard, Jesper [1 ]
Johansson, Paer Ingemar [2 ,4 ]
Hassager, Christian [1 ,4 ]
机构
[1] Copenhagen Univ Hosp, Rigshospitalet, Dept Cardiol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
[2] Copenhagen Univ Hosp Rigshospitalet, Ctr Endotheli, Dept Clin Immunol, CAG, Copenhagen, Denmark
[3] Odense Univ Hosp, Dept Cardiol, Odense, Denmark
[4] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
来源
INTENSIVE CARE MEDICINE EXPERIMENTAL | 2025年 / 13卷 / 01期
关键词
Cardiac arrest; Glucocorticoid; Methylprednisolone; Metabolomics; Inflammation; EUROPEAN RESUSCITATION COUNCIL; INDOLEAMINE 2,3-DIOXYGENASE; KYNURENINE PATHWAY; EARLY PREDICTION; EPIDEMIOLOGY; DEATH;
D O I
10.1186/s40635-025-00754-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background and aimPatients resuscitated after out-of-hospital cardiac arrest (OHCA) face high morbidity and mortality rates, primarily due to ischemia-reperfusion injury, a complex metabolic disorder that triggers a significant systemic inflammatory response. Glucocorticoids mitigate inflammation but also impact the cells beyond the immune response. This study aims to identify glucocorticoid effects on plasma metabolites.MethodsThis explorative sub-study is part of a two-center, blinded, randomized controlled trial (NCT04624776) examining the effects of high-dose glucocorticoid on comatose patients resuscitated from OHCA of presumed cardiac origin. Following resuscitation, patients received 250 mg of methylprednisolone or a placebo in the prehospital setting. Blood samples were collected upon hospital admission and 48 h later. Sixty metabolites were quantified in the plasma using mass spectrometry and compared between groups.ResultsIn the modified intention-to-treat population, 68 patients received methylprednisolone, and 69 received placebo [median age was 66 years (IQR: 56-74) and 83% were men]. Blood samples were available for 130 patients, 121 (88%) at admission and 117 patients (94% of patients alive) after 48 h. Although a nominal difference was observed at admission, no significant metabolic effects were found after correcting for multiple testing. After 48 h, the placebo group had 83.4% (95% CI 16.9-187.6%) higher prostaglandin E2 and higher levels of linolenic acid and arachidonic acid. The methylprednisolone group had higher levels of tryptophan (47.6%; 95% CI 27.9-70.2%), arginine, and propionylcarnitine (C3).ConclusionsIn this exploratory study, early administration of 250 mg of methylprednisolone after resuscitation appeared to drive sustained metabolic effects over 48 h. Specifically, methylprednisolone led to reductions in omega-6 fatty acids and increases in several amino acids, with a notable rise in tryptophan.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Out-of-hospital cardiac arrest
    Porzer, Martin
    Mrazkova, Eva
    Homza, Miroslav
    Janout, Vladimir
    BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (04): : 348 - 353
  • [2] Inflammatory response after prehospital high-dose glucocorticoid to patients resuscitated from out-of-hospital cardiac arrest: A sub-study of the STEROHCA trial
    Obling, Laust E. R.
    Beske, Rasmus P.
    Meyer, Martin A. S.
    Grand, Johannes
    Wiberg, Sebastian
    Damm-Hejmdal, Anders
    Bjerre, Mette
    Frikke-Schmidt, Ruth
    Folke, Fredrik
    Moller, Jacob E.
    Kjaergaard, Jesper
    Hassager, Christian
    RESUSCITATION, 2024, 202
  • [3] Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial
    Obling, Laust E. R.
    Beske, Rasmus P.
    Meyer, Martin A. S.
    Grand, Johannes
    Wiberg, Sebastian
    Mohr, Thomas
    Damm-Hejmdal, Anders
    Forman, Julie L.
    Frikke-Schmidt, Ruth
    Folke, Fredrik
    Moller, Jacob E.
    Kjaergaard, Jesper
    Hassager, Christian
    CRITICAL CARE, 2024, 28 (01)
  • [4] Prehospital high-dose methylprednisolone in resuscitated out-of-hospital cardiac arrest patients (STEROHCA): a randomized clinical trial
    Obling, Laust E. R.
    Beske, Rasmus P.
    Meyer, Martin A. S.
    Grand, Johannes
    Wiberg, Sebastian
    Nyholm, Benjamin
    Josiassen, Jakob
    Sondergaard, Frederik T.
    Mohr, Thomas
    Damm-Hejmdal, Anders
    Bjerre, Mette
    Frikke-Schmidt, Ruth
    Folke, Fredrik
    Moller, Jacob E.
    Kjaergaard, Jesper
    Hassager, Christian
    INTENSIVE CARE MEDICINE, 2023, 49 (12) : 1467 - 1478
  • [5] Incidence and Outcomes of Rearrest Following Out-of-Hospital Cardiac Arrest
    Salcido, David D.
    Sundermann, Matthew L.
    Koller, Allison C.
    Menegazzi, James J.
    CIRCULATION, 2013, 128 (22)
  • [6] Recurrent out-of-hospital cardiac arrest
    Nehme, Ziad
    Andrew, Emily
    Nair, Resmi
    Bernard, Stephen
    Smith, Karen
    RESUSCITATION, 2017, 121 : 158 - 165
  • [7] Effect of prehospital high-dose glucocorticoid on hemodynamics in patients resuscitated from out-of-hospital cardiac arrest: a sub-study of the STEROHCA trial
    Laust E. R. Obling
    Rasmus P. Beske
    Martin A. S. Meyer
    Johannes Grand
    Sebastian Wiberg
    Thomas Mohr
    Anders Damm-Hejmdal
    Julie L. Forman
    Ruth Frikke-Schmidt
    Fredrik Folke
    Jacob E. Møller
    Jesper Kjaergaard
    Christian Hassager
    Critical Care, 28
  • [8] Out-of-Hospital Cardiac Arrest
    Gerecht, Ryan B.
    Nable, Jose, V
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2023, 41 (03) : 433 - 453
  • [9] Out-of-Hospital Cardiac Arrest
    Gerecht, Ryan B.
    Nable, Jose, V
    CARDIOLOGY CLINICS, 2024, 42 (02) : 317 - 331
  • [10] Out-of-Hospital Cardiac Arrest
    Boyd, Tanner S.
    Perina, Debra G.
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2012, 30 (01) : 13 - +